• 31 May 24

Braemar – executive interview (31 May 2024)

Braemar – executive interview (31 May 2024)

Braemar PLC | BMS | 258 7.5 0.1%

    • 203 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Audio Note: Braemar and Clarkson - Tariffs, Shipping and the Shipbrokers

Companies: Braemar PLC (BMS:LON)Clarkson PLC (CKN:LON)

Optima Health, Iofina, Genflow Biosciences - Small Cap Week in Review

Companies: Optima Health PLC

Braemar (BMS) Half Year 2025 results presentation - November 2024

Companies: Braemar PLC

Solvonis Therapeutics CEO discusses £2mln raise aimed at completing acquisition of Awakn and progressing AUD programs

Companies: Solvonis Therapeutics Plc

Braemar (BMS) Full Year 2024 results presentation - May 2024

Companies: Braemar PLC

Optima Health grows 7%, eyes further acquisitions

Companies: Optima Health PLC

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top